Fellowship
The Investigational Cancer Therapeutics Fellowship Program provides a one-, two-, or three- year experience in early drug development. Fellows are trained in developing and conducting innovative clinical/translational trials with novel, targeted agents and are prepared for careers in academics, the pharmaceutical industry, or government.
MD Anderson Cancer Center provides a rich experience for fellows. Over 108,000 patients were seen here last year, and almost 10,000 were placed on therapeutic trials. In FY2011, our department alone had over 127 therapeutic trials and enrolled about 1200 patients on our protocols. About one-third of our Phase I trials are first-in-human studies.
There is a wealth of opportunity for interactions with a wide variety of investigators who are internationally known for their expertise in basic, translational and/or clinical science. Fellows will learn how to write trials, interact with sponsors, develop translational endpoints to understand drug impact and factors predicting response and host toxicity, present data at national or international meetings, analyze data and write/complete manuscripts.
Application Requirements
Program applicants should have:
- a M.D. degree
- completed an internal medicine residency or equivalent training
- an interest in a career in drug development
- passed the licensure exam (USMLE Steps 1 & 2)
- Foreign-trained applicants must have ECFMG Certification.
Although completion of medical oncology training is not a requirement, fellows who have completed this training will be highly competitive for a fellowship position.
The department sponsors J-1 visas, but not H-1B visas.
For questions or to apply for fellowship training, please contact:
David S. Hong MD
Deputy Chair
Associate Professor of Medicine
Department of Investigational Cancer Therapeutics [Phase I Clinical Trials Program]
Division of Cancer Medicine
Clinical Medical Director, Clinical Center for Targeted Therapy
Director, Investigational Cancer Therapeutics Fellowship
MD Anderson Cancer Center, Unit 455
P.O. Box 301402
Houston, TX 77230-1402
Phone 713-563-5844
Fax 713-563-0566
E-mail: dshong@mdanderson.org
Denise De La Cruz Baum, M.Ed
Program Manager, Educational Programs
Department of Investigational Cancer Therapeutics - Unit 455
Division of Cancer Medicine
P.O. Box 301402
Houston, TX 77230-1402
Phone: 713-563-0632
Fax: 713-792-0334
E-mail: ddbaum@mdanderson.org
Resources
Observer Program
We offer one short-term observer position each month.
Appointments & Referrals
For a referral to clinical trials with a new targeted drug, call (713) 792-1160, or visit our Contact Information page.